Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Acute myeloid leukemia (AML) is a heterogeneous disease, and there are critical interests in detecting multiple biomarkers as a single biomarker detection cannot reflect the exact phase of the disease. Exosomes derived from different types of AML cells contain respective combinations of cluster of differentiation (CD) markers that may be used to guide the molecular typing of AML in the clinic. This service provides a method promising in sensitive detection of multitargets to assist in the precise molecular typing of many complex diseases.